Start of commercial production in Pomacle
First batches manufactured in March 2022 Commercial launch at In-Cosmetics in Paris Scale-up trajectory accelerated Paris, 24 March 2022 – Global Bioenergies announces the start of production at its…
Read More Global Bioenergies publishes annual financial results
Group net loss of €11.8m in 2021 Gross cash position of €20.9m at 31 December 2021 Paris, 2 March 2022: The Board of Directors of Global Bioenergies, at its…
Read More A new molecule for the greening of C5 chemistry
Evry, 09 February 2022 Global Bioenergies has developed a process for converting plant resources into isobutene, one of the main building blocks of chemistry, whose derivatives are used in cosmetics,…
Read More LAST® wins Marie Claire Prix d’Excellence Beauty Award 2022
Paris, 4 February 2022 For 36 years, Marie Claire, a magazine sold in over 30 countries and read by over 75 million women worldwide, has assembled a panel of experts…
Read More €500,000 subsidy granted to Global Bioenergies by the Grand Est region as part of the France Relance plan
Evry, 01 February 2022: Global Bioenergies has been awarded a €500,000 subsidy to complete construction of the Pomacle production unit and start marketing its innovative ingredients to the cosmetics industry.…
Read More TP ICAP Midcap initiates coverage of Global Bioenergies share
Evry, 31 January 2022: TP ICAP Midcap has initiated coverage of the Global Bioenergies share (Euronext Growth: ALGBE) and today publishes a detailed analysis for its clients describing the Group’s…
Read More Global Bioenergies successfully completes a fundraising for a total amount of €14.5 million
No Comments
Evry, 14 December 2021: Global Bioenergies (the “Company”) is today announcing the successful completion of its capital increase for a total amount of €14.5M, without preferential subscription rights for shareholders…
Read More 
